VENOUS THROMBOEMBOLIC DISEASE
Clinical trials for VENOUS THROMBOEMBOLIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLIC DISEASE trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill vs. shot: new hope for preventing deadly clots in cancer patients
Prevention Recruiting nowThis study is testing if blood thinner pills (apixaban or rivaroxaban) are as safe and effective as standard daily shots (low-molecular-weight heparin) at preventing dangerous blood clots in people being treated for blood cancers like leukemia, lymphoma, or multiple myeloma. Abou…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Can a 3-Month blood thinner regimen stop deadly clots in rare blood disease?
Prevention Recruiting nowThis study is testing whether taking blood-thinning medication for 12 weeks can prevent dangerous blood clots in people newly diagnosed with or having a relapse of autoimmune hemolytic anemia (AIHA). AIHA is a rare condition where the immune system attacks red blood cells, and pa…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC
-
Major chinese trial aims to stop hospital blood clots
Prevention Recruiting nowThis large study is testing whether a hospital-wide quality improvement program can help prevent dangerous blood clots in patients during and after their hospital stay. It will involve 5,800 patients across multiple hospitals in China. Some hospitals will use the new program, whi…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Prevention
Last updated Mar 18, 2026 14:41 UTC